Lee is SVP of Business Development at Systems Oncology.
Systems Oncology is focused on developing breakthrough therapies for cancer. We do that by applying advanced computational research to accelerate the discovery and development of novel drugs - with a focus on innovative drugs that have new mechanisms of action.
We have a library of assets that we invest in and amplify the most promising experimental agents to demonstrate their therapeutic potential. Finally, we partner with pharmaceutical companies to transform these innovative new agents into breakthrough cancer therapies.